DYNamic Assessment of Multi-Organ level dysfunction in patients recovering from COVID-19: DYNAMO COVID-19.
Ayushman GuptaRosemary NicholasJordan J McGingAline V NixonJoanne E MallinsonTricia M McKeeverChristopher R BradleyMathew PiaseckiEleanor F CoxJames BonningtonJanet M LordChristopher E BrightlingRachael A EvansIan P HallSusan T FrancisPaul L GreenhaffCharlotte E BoltonPublished in: Experimental physiology (2024)
We evaluated the impacts of COVID-19 on multi-organ and metabolic function in patients following severe hospitalised infection compared to controls. Patients (n = 21) without previous diabetes, cardiovascular or cerebrovascular disease were recruited 5-7 months post-discharge alongside controls (n = 10) with similar age, sex and body mass. Perceived fatigue was estimated (Fatigue Severity Scale) and the following were conducted: oral glucose tolerance (OGTT) alongside whole-body fuel oxidation, validated magnetic resonance imaging and spectroscopy during resting and supine controlled exercise, dual-energy X-ray absorptiometry, short physical performance battery (SPPB), intra-muscular electromyography, quadriceps strength and fatigability, and daily step-count. There was a greater insulin response (incremental area under the curve, median (inter-quartile range)) during the OGTT in patients [18,289 (12,497-27,448) mIU/min/L] versus controls [8655 (7948-11,040) mIU/min/L], P < 0.001. Blood glucose response and fasting and post-prandial fuel oxidation rates were not different. This greater insulin resistance was not explained by differences in systemic inflammation or whole-body/regional adiposity, but step-count (P = 0.07) and SPPB scores (P = 0.004) were lower in patients. Liver volume was 28% greater in patients than controls, and fat fraction adjusted liver T 1 , a measure of inflammation, was raised in patients. Patients displayed greater perceived fatigue scores, though leg muscle volume, strength, force-loss, motor unit properties and post-exercise muscle phosphocreatine resynthesis were comparable. Further, cardiac and cerebral architecture and function (at rest and on exercise) were not different. In this cross-sectional study, individuals without known previous morbidity who survived severe COVID-19 exhibited greater insulin resistance, pointing to a need for physical function intervention in recovery.
Keyphrases
- end stage renal disease
- magnetic resonance imaging
- ejection fraction
- chronic kidney disease
- insulin resistance
- type diabetes
- newly diagnosed
- physical activity
- blood glucose
- coronavirus disease
- peritoneal dialysis
- randomized controlled trial
- blood pressure
- computed tomography
- cardiovascular disease
- heart failure
- high fat diet
- metabolic syndrome
- skeletal muscle
- high intensity
- adipose tissue
- magnetic resonance
- mass spectrometry
- nitric oxide
- depressive symptoms
- patient reported
- heart rate
- glycemic control
- heart rate variability
- single molecule
- left ventricular
- subarachnoid hemorrhage
- body composition
- weight loss
- bone mineral density
- atrial fibrillation